Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  CGC | T.WEED.DB

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.


TSX:WEED - Post by User

Comment by Rotalucepson Jun 11, 2022 5:09am
124 Views
Post# 34748981

RE:RE:Pathetic

RE:RE:Pathetic
angelnicky wrote: it will go back up in time (years if you can wait)
may test 2.00 before it starts back up
company should of offered shares when it was in 20's for working capital
now should a share offering take place it will increase dilution



If I think a stock will reach $2.00, I will not wait. What a weird way of thinking. The prospect doesn't look good for many years. The mj companies all face the same problems, lack of revenue because of the big competition, bad management, the tax, the complicated laws to name a few. 


If the Senate vote is positive, they will enter the US in an already huge competition. The best thing to do for the long is to stay on the side (I wrote this on May 27), at least they will not lose more. CGC will be "adjusted" EBITDA positive in 2024 ---> 24. Though, I would take this with a grain of salt since the companies missed their target. This saga will last for years.

It is not even EBITDA, but "adjusted". It is obvious there is too much competition and it will not change. Cannabis is becoming a cheaper product and the huge profit we all thought we would do some years ago is gone, finish. Now this is a game for dreamer. I want to specify it is about the Can market. I don't buy the US either. 

Then are we heading for a severe correction. The DOW was down 880 yesterday. I own no shares. I will probably buy WEED if the Senate vote is positive, the vote being before the August recess, when, I don't know. I will play the news since the legalisation will push the sector. I will sell when I find it adequate. It will not be a long position. The competition is already stiff in the US, entering the US will not do any miracle for them. 
<< Previous
Bullboard Posts
Next >>